New trends in Alzheimer disease management

New trends in Alzheimer disease management

  Abstact The identification and validation of biomarkers for diagnosing Alzheimer’s disease (AD) and other forms of dementia are critically important. Until now ELISA measurement of β-amyloid(1–42), total Tau and phospho-Tau (181P) in cerebrospinal fluid (CSF) were the most advanced and accepted method to diagnose probable AD with high specificity and sensitivity. Today automated assays … Continued

Read more